Protease inhibitors

BMS 300 mg 3622 Pill - red blue capsule-shape, 23mm

Generic Name: atazanavir

Pill with imprint BMS 300 mg 3622 is Red / Blue, Capsule-shape and has been identified as Reyataz 300 mg. It is supplied by Bristol-Myers Squibb.

Reyataz is used in the treatment of Nonoccupational Exposure; HIV Infection and belongs to the drug class protease inhibitors. There is no proven risk in humans during pregnancy. Reyataz 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images

Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 300 mg 3622-300 mg-Red / Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 300 mg 3622-300 mg-Red / Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 300 mg 3622-300 mg-Red / Blue-Capsule-shape
Reyataz (Atazanavir [ a-ta-zan-a-vir ])-BMS 300 mg 3622-300 mg-Red / Blue-Capsule-shape

Reyataz
Generic Name: atazanavir [ a-ta-zan-a-vir ]
Imprint: BMS 300 mg 3622
Strength: 300 mg
Color: Red / Blue
Size: 23.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Protease inhibitors
Pregnancy Category: B - No proven risk in humans
CSA Schedule: Not a controlled drug
Labeler / Supplier: N/A
National Drug Code (NDC): N/A
Inactive Ingredients: Lactose monohydrate, Magnesium stearate, FD&C Blue No. 2, Titanium dioxide, Ferric oxide red, Ferric oxide yellow, Isopropyl alcohol, Ammonia, Propylene glycol, Butyl alcohol, Alcohol, Ferrosoferric oxide, Shellac,
Latest News
Related Drugs